GNFT Financials: Genfit SA AI Analysis

Home

Stock

GNFT

Financials

GNFT Financial

Genfit SA

$8.95

4.06%

$0.34

At close: Mar 24, 16:00:00 GMT-4

$8.95

Post-market: Mar 24, 17:47:13 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$8.6

Open

Day's Range

$8.85 - $9

52 week range

$2.55 - $8.95

Volume

4.2K

Avg.Volume

9.8K

Dividend yield

EPS (TTM)

-0.90

Market Cap

$447.5M

What is GNFT?

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company is headquartered in Loos, Hauts-De-France and currently employs 188 full-time employees. The company went IPO on 2006-12-19. The firm provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The firm leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

GNFT Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	45	70	38	26	85	7
Revenue Growth (YoY)	-46%	84%	46%	-69%	1,114%	-83%
Cost of Revenue	2	2	2	2	1	2
Gross Profit	43	68	36	24	84	5
Selling, General & Admin	8	8	8	7	8	18
Research & Development	40	34	35	27	27	50
Operating Expenses	71	65	62	51	51	83
Other Non Operating Income (Expenses)	-8	0	1	0	0	0
Pretax Income	-39	1	-28	-23	69	-101
Income Tax Expense	0	0	0	0	2	0
Net Income	-38	1	-28	-23	67	-101
Net Income Growth	-273%	-104%	22%	-134%	-166%	55%
Shares Outstanding (Diluted)	49.78	49.94	49.7	49.67	55.61	38.85
Shares Change (YoY)	-18%	0%	0%	-11%	43%	5%
EPS (Diluted)	-0.77	0.03	-0.58	-0.47	1.2	-2.6
EPS Growth	-314%	-105%	22%	-139%	-146%	48%
Free Cash Flow	-6	14	-57	-72	99	-97
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	95.55%	97.14%	94.73%	92.3%	98.82%	71.42%
Operating Margin	-60%	4.28%	-68.42%	-103.84%	37.64%	-1,100%
Profit Margin	-84.44%	1.42%	-73.68%	-88.46%	78.82%	-1,442.85%
Free Cash Flow Margin	-13.33%	20%	-150%	-276.92%	116.47%	-1,385.71%
EBITDA	-26	4	-25	-26	34	-74
EBITDA Margin	-57.77%	5.71%	-65.78%	-100%	40%	-1,057.14%
D&A For EBITDA	1	1	1	1	2	3
EBIT	-27	3	-26	-27	32	-77
EBIT Margin	-60%	4.28%	-68.42%	-103.84%	37.64%	-1,100%
Effective Tax Rate	0%	0%	0%	0%	2.89%	0%

Follow-Up Questions

What are Genfit SA's key financial statements?



According to the latest financial statement (Form-10K), Genfit SA has a total asset of $151, Net profit of $1

What are the key financial ratios for GNFT?



Genfit SA's Current ratio is 1.84, has a Net margin is 1.42, sales per share of $1.4.

How is Genfit SA's revenue broken down by segment or geography?



Genfit SA largest revenue segment is Innovative Medicines and Diagnostic Solutions, at a revenue of 67,001,999 in the most earnings release.For geography, France is the primary market for Genfit SA, at a revenue of 67,001,999.

Is Genfit SA profitable?



yes, according to the latest financial statements, Genfit SA has a net profit of $1

Does Genfit SA have any liabilities?



yes, Genfit SA has liability of 82

How many outstanding shares for Genfit SA?



Genfit SA has a total outstanding shares of 49.99

Genfit SA (GNFT) Financial

GNFT Stock Price Chart